CPG SUMMARYAn Executive Summary of the Clinical Practice Guideline: Diagnosis of Upper-Quadrant Lymphedema Secondary to CancerDavies, Claire PT, PhD, CLT-LANA1; Levenhagen, Kimberly PT, DPT, WCC2; Ryans, Kathryn PT, DPT, CLT-LANA3; Perdomo, Marisa PT, DPT4; Gilchrist, Laura PT, PhD5Author Information 1Rehabilitation Services Baptist Health Lexington, Lexington, KY 2Department of Physical Therapy & Athletic Training, Doisy College of Health Sciences, St Louis University, St Louis, MO 3Doctor of Physical Therapy Program, Mercy College, Dobbs Ferry, NY 4Division of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, CA 5Doctor of Physical Therapy Program, St Catherine University, Minneapolis, MN Correspondence: Laura Gilchrist, PT, PhD, Doctor of Physical Therapy Program, St Catherine University, 601 25th Ave S, Minneapolis, MN 55454 (firstname.lastname@example.org). Grant Support: This article was supported by a grant from APTA.The authors have no conflicts of interest to declare. Rehabilitation Oncology: July 2017 - Volume 35 - Issue 3 - p 114-118 doi: 10.1097/01.REO.0000000000000075 Buy Metrics Abstract Secondary upper-quadrant lymphedema (SUQL) is a complication of cancer treatments that may impact a large number of cancer survivors. To identify lymphedema early, it is important to determine which diagnostic tools yield the best accuracy so that early intervention can minimize impairments and potentially reduce the cost of disease management while not misdiagnosing patients. The purpose of this executive summary is to briefly describe the major findings of the clinical practice guideline and provide current recommendations for evidence-based diagnostic methods and criteria for cancer-related SUQL. © 2017 Oncology Section, APTA.